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LVM indexed by BSA** Height* Height2.7 LBM** 
Male 73 _+ 16 g/m 2 89 ± 21 g/m 33 ± 7 g/m 2"7 2.68 ± 0.52 g/kg 
Female 64± 13 g/m 2 75 ± 13 g/m 33 ± 6 g/m2.7 3.07 ± 0.60 g/kg 
1108-96 Arterial Stiffness and Left Ventricular Geometry and 
Function in Hypertensive Patients With 
Electrocardiographic Left Ventricular Hypertrophy: The 
LIFE Study 
Vittorio Palmieri, Jonathan N. Bella, Mary J. Roman, Eva Gerdts, Vasilios 
Papademetriou, Kristian Wachtell, Markku S. Nieminen, Bj6rn Dahl6f, Richard B. 
Devereux, WeN Medical College of Come//Universi~ New York, New York. 
Background: Arterial stiffness can be assessed by the ratio pulse pressure (PP) over 
echocerdiographic stroke volume (SV). We evaluated relations of arterial stiffness to left 
ventricular (LV) geometry and function in hypertensive patients with electrocardiographic 
(ECG) LV hypertrophy (H). 
Methods: Of participants in the echo-substudy of the Losartan Intervention For Endpoint 
(LIFE) reduction in hypertension study, selected to have ECG-LVH by Cornell voltage-dura- 
tion product or Sokolow-Lyon voltage criteria, no heart failure or severe aortic stenosia, we 
identified 858 subjects (88%, 66+-7 yrs/old) with PP/SV available. The study sample was 
divided in tertiles of PP/SV (cutpoints: 0.86 and 1.11 mm Hg/ml). M-mode and Doppler SV 
were averaged. 
Results: With higher PP/SV, age, proportions of women and diabetics, and systolic blood 
pressure (BP) were higher (all p<0.01); diastolic BP, body height and weight, and SV were 
lower (all p<0.01). Mean BP, totaVHDL cholesterol, urinary albumin/creatinine and propor- 
tion of wall motion abnormalities were similar in tertiles of PP/SV. After adjusting for age, 
gender and body surface area, LV mass and LV intemal diameter were lower while relative 
wall thickness (RWT=LV concentricity) was higher with higher PP/SV (all p<0.01); ejection 
fraction was similar across tertiles (p>0.5) while stress-corrected midwall shortening 
(scMWS) was lower with higher PP/SV (p<0.01). After adjustment for age and gender, LV 
filling parameters and heart rate were similar in tertiles of PP/SV (all p>O.1). In multivariate 
models, independent correlates of PP/SV were older age, lower body weight, female-gen- 
der end diabetes (R=0".48, p<0.00t); higher RWT was related to higher PP/SV independent 
of age, gender, and mean BP (R=0.30, p<0.001); higher LV mass was independently pre- 
dicted by higher SV, male-gender, higher body weight, older age and higher mean BP, but 
not PP (R=0.64, p<0.001); PP/SV was not related to scMWS independent of RWT. 
Conclusions: In elderly hypertensives with ECG-LVH, higher arterial stiffness is related to 
concentric LV geometry, which may offset afterload and preserve LV chamber function, but 
is associated with impaired myocardial function. 
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825FO-2 Add i t ion  of  StaUn Attenuates the Increase in C-React ive 
Protein During Estrogen Replacement Therapy in 
Postmenopeuee l  Women 
Kwano K. Koh, Gyorgy Cseko, William Schenke, Richard O. Cannon, III, NHLBI, 
Bethesda, Maryland. 
Background: Randomized clinical trials have shown that HMG-CoA reductase inhibitor 
(statin) therapy reduces cardiovascular risk, the mechanism of which may include dimin- 
ished arterial inflammation as evidenced by reduction in levels of C-reactive protein (CRP) 
in serum, Because estrogen replacement therapy increases CRP in postmenopausal 
women, which coutd have pro-inflammatory consequences and compromise any benefit to 
cardiovascular risk, we determined whether the addition of statin might modify the estro- 
genic effect on CRP. Methods: in a double blind, 3-period crossover study, we randomly 
assigned 28 healthy postmenopausel women to conjugated equine estrogens (CEE) 0.625 
rag, simvastatin 10 rag, and their combination daily for 6 weeks, with each treatment period 
separated by 6 weeks off drugs. CRP was measured by high sensitivity immunomethc 
assay (sensitivity 0.01mg/dL) before and after 6 weeks of each treatment. Results: CEE 
increased CRP from 0.37 ± 0.06 to 0.65 ± 0.13 mg/dL, simvastatin decreased CRP from 
0.37 ± 0.06 to 0.33 ± 0.05 mg/dL, and the therapies combined increased CRP from 0.38 ± 
0.08 to 0.48 ± 0.08 mg/dL (all P<0.02 vs. respective baseline values), with significant differ- 
ences in changes in CRP levels among these therapies (P<O.05 by ANOVA). Post-hoc 
testing showed that the 29 ± 8 % increase in CRP on the combination of CEE with simvas- 
tatin was significantly less than the 89 ± 32 % increase in CRP on CEE alone (P<0.0t). 
The effect of combination therapy on CRP did not correlate with baseline CRP, or with 
baseline or traatment-inducod changes in levels of LDL cholesterol, HDL cholesterol, inter- 
leukin-6, or brachlal artery flow-mediated ilation as a measure of nitric oxide bioactivity (all 
r<0.32). Conclusion: The combination of statin with estrogen therapy may attenuate the 
potential preinflammatory effect of estrogen administration to postmenopausat women, and 
maximize any benefit of hormone replacement herapy to cardiovascular isk. 
2:30 p.m. 
825FO-3 The Dif ferent ia l  Effects of Hormone Replacement 
Therapy and Selective Estrogen Receptor Modulator on 
Endothelial Function Seem Related to  an Effect on 
Plasma Asymmetric Dimethylarglnine, an Inh ib i tor  o f  
Nitr ic Ox ide  Syntheee  
Giuseppe Mercuro, Massimo Fini, Cristiana Vitale, Otavio Gebara, Sandra Zoncu, 
Mauricio Wajngarten, Antonello Silvestri, Paola Rossini, Josh Antonio E Ramires, 
Giuseose M. Rosano, San Raffae/e Hospital, Rome,/ta/y, University of Cag/ia~ 
Cag/ia~ Italy. 
Background: Hormone replacement therapy (HRT) improves endothelial function in 
postmenopausal women. Although in vitro animal studies suggest that the selective 
estrogen receptor modulator, raloxifene (R), improves endothelial function, its effect in 
women has yielded conflicting results. One mechanism by which HRT may reverse 
endothelial dysfunction and increase NO bioavaitability is by lowering asymmetric dime- 
thylarginine (ADMA), an endogenous inhibitor of nitric oxide (NO) synthase. The aim of 
this study was to evaluate endothelial function and plasma ADMA with HRT or R. 
Methods: Brachlal artery diameter, endothelium-dependent flow-mediated vasodilation 
(FMD) of the brachial artery, and plasma levels of nitrite, nitrate, endothelin-1 and ADMA 
were measured in 20 bostmenopausel women with increased cardiovascular risk, treated 
with either HRT (0.625 conjugated equine estrogens and 2.5 mg medroxyprogesterone 
acetate) or R (60 rag) for 4 weeks in a double-blind, single cross-over study. 
Results: Baseline brechial artery diameters remained unchanged after each treatment 
phase. FMD significantly improved with HRT but not with R. ADMA significantly 
decreased with HRT, while a trend towards increased plasma ADMA levels was noted 
with R. 
Conclusions: HRT improves endothelial function in postmenopausel women at risk of 
cardiovascular disease, which may be due, at least in part, to a reduction in ADMA. In 
contrast, R seems to increase plasma ADMA, which may negatively affect endothelial 
function. 
Baseline HRT R 
FMD (%) 7.4_+.0.5 12.4+_0.6"* 6.1+_2.0 
ADMA 0.76+0.51 0.68_+0.63** 0.80+_0.65 
Nitrite+nitrate (Nox) 41.1_+10.3 47.3+-8.4* 38.8+-6.8 
Endothelin-1 (pg/ml) 3.2+_0.6 2.8_+0.6* 3.2+0.7 
*=p<0.05; **=p<0.01, compared to baseline 
2:45 p.m. 
825FO-4 Hormone Replacement Therapy and Risk of Myocardial 
Infarction in Women With Diabetes 
Aooor S. Gami, R. Scott Wright, Sharonne E. Hayes, Stephen L. Kopecky, Mayo Clinic, 
Rochester, Minnesota. 
Background: The effect of hormone replacement herapy (HRT) on coronary heart disease 
(CHD) in postmenopausal women is controversial Women with diabetes are at markedly 
increased risk of CHD, yet data on HRT in this population is scarce. The purpose of this 
study is to describe the effect of HRT on risk of MI in postmenopausel women with diabetes. 
Methods: We conducted a case-control study in which case subjects (n = 99) were consec- 
utive postmenopausal women with diabetes admitted to our institution from 1998 to 2000 
with a principal diagnosis of ML Control subjects (n = 306), matched in a 3:1 ratio by age 
and admission year, were postmenopausal women with diabetes admitted with principal 
diagnoses other than MI. Medical records were reviewed for demographics, medical history 
including diabetes complications, CHD risk factors, laboratory data, and current medica- 
tions. Differences between case and control groups were assessed by the two-sample T- 
test for continuous variables and the chi-square test for dichotomous variables. The odds 
ratio, adjusted for group differences by logistic regression models, was used to estimate the 
relative risk of incident MI for HRT users. 
Results: Case and control subjects were of similar age (73 years), height (157 cm), and 
weight (77 kg). Case and control groups had similar frequencies of hypertension (73°/°) and 
active cigarette use (8%). Frequencies of use of insulin (53%), oral hypoglycemic agents 
(36%), aspirin (46%), and statins (22%) were similar. Frequencies of diabetic retinopathy 
(19%), neuropethy (21%), and nephropathy (32%) were similar. Average levels of hemoglo- 
bin Alc (8.6%) and creatinine (1.7 mg/dt) were similar. More case subjects had previous MI 
(29% vs. 17°, p = 0.01) and hypercholesterolemia (52% vs. 39%, p = 0.02). Current users 
of estrogen (with or without progesterone) comprised 16% of case and 18% of control sub- 
jects. The relative risk of incident MI for current HRT users was 0.92 (95% CI 0.44 - 1.94). 
assessing body composition and LVM, we examined the gender difference of LVM adjusted 
for LBM in older persons with mild hypertension. 
Method: Fifty-two subjects (22 men and 30 women) with untreated mild hypertension, aged 
55 to 75 years, and otherwise healthy, were examined. Resting BP was obtained at 4 or 5 
visits at least 1 week apart and averaged. Body composition was assessed using dual 
energy X-ray absorptiometry. LVM was determined from MRI and was indexed by BSA, 
height, height 2'7 and LBM. 
Results: There were no gender differences in age, SBP and BMI. Men had higher mean BP, 
uniodexed LVM, and LBM than women. Fat mass and percent body fat were higher in 
women compared to men. Unlike the LVM indexed by other measures, LVM indexed by LBM 
was greater in women than men, as shown in table. In a multiple regression model, gender 
was a predictor of LVM after adjustment for LBM, mean BP, percent body fat and LBM - gen- 
der interaction (adjusted means, female vs. male, 135 ± 8 g vs. 109 ± 12 g, p < 0.05) 
Conclusion: in this population of older persons with mild hypertension, women had a higher 
LVM relative to their lean body size, suggesting that women may be more susceptible to LVH 
than men. 
Table * p < 0.01, ** p < 0.05, male vs. female 
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Similar results were obtained after adjustment for MI and hypemholestere~emia. 
Conclusion: This case-contrel study provides evidence that current HRT use neither 
increases nor decreases the risk of incident MI in postmenopausel women with diabetes. 
3:00 p.m. 
825FO-5 Prothrombotic Mutations Are Associated With 
Increased Cardiovascular Events in Postmenopausal 
Women Receiving Hormone Replacement Therapy 
Francesco Dragoni, Otavio Gebara, Massimo Fini, Mauricio Wajngarten, Jost~ Mendes 
Alddghi, Giuseppe Mercuro, Jos~ Antonio F. Ramires, GiuseoDe M. Rosano. San 
Raffaele Hospital, Roma, Italy, INCOR, Sao Paulo, Brazil. 
Recent studies have suggested that hormone replacement therapy (HRT) in postmeno- 
pausal women (PMW) may be associated with an initial increased cardiovascular isk. 
Recent reports suggest that the prothrombin variant 20210G to A is associated with an 
increased risk of events in hypertensive PMW with a previous myocardial infarction. To 
this end 50 PMW with documented vascular event underwent prospective valuation of 
antithrombin III, protein C, free and total protein S, activated protein C resistance, fibrino- 
gen, factor VII:C and homocysteine levels. In all the presence of antiphospholipid anti- 
bodies was investigated by kaolin clotting time (KCT), diluted Russers viper venom time 
(DRVVT) end by measurement of anticardiolipin antibodies IgG and IgM (ACA-G and 
ACA-M). Prevalence of factor V Leiden, prothrombin variant G20210A and homozygosity 
for thermolabile variant C677T of the metilenetetrahydrofolate reductase (MTHFR) were 
evaluated and compared with those of 50 normal matched controls. 
Antithrombin l and protein C were normal in all cases. One patient (2%) showed free 
protein S deficiency and 3 patients (6%) had activated protein C resistance. Homocys- 
teine levels above 15 tJmol/L were found in 3 patients (6%). Antiphospholipids antibodies 
were found in 35 patients (70%). Among women receiving HRT 87% had combined 
inhedted and acquired prothrombotic factors (OR = 37.3, 95% CI = 8.5-564.3) while no 
combined prothrombotic factors were found in control PMW receiving HRT. 
In conclusion vascular events in women receiving RRT are associated with a high preva- 
lence of combined inherited and acquired prothrombotic factors. Therefore screening for 
prothrombotic factors may be of help in identify those women at increased risk for cardio- 
vascular events with HRT. 
3:15 p.m. 
825FO-6 Different Effect of Hormone Replacement Therapy, 
DHEAS, and Tibolone on Endothelial Function in 
Postmenopausel  Women With Increased 
Cardiovascular Risk 
Cdstiana Vitale, Otavio Gebara, Massimo Fini, Mauricio Wajngarten, Jos~ Mendes 
Alddghi, Antonello SUvestd, Paola Rossini, Sandra Zoncu, Cdstiano Sarais, Jos~ Antonio 
Ramires, Giuseppe Mercuro, Giuseooe M. Rosano. San Raffaele Hospital, Roma, Italy, 
INCOR, Sao Paulo, Brazil. 
Menopause is associated with an increased cardiovascular isk and with a decrease in 
endothelial function Hormone replacement herapy (HRT) improves endothelial function 
in post-menopausal women (PMW). New alternative treatments for menopausal women 
have been suggested among these Tibolone iT) and di-hydroepiandresterone sulphate 
(DHEAS) have been suggested to have cardioprotsctive ffects, Although in vitro animal 
studies have suggested that T and DHEAS improve endothelial function, their effect in 
humans has never been tested, Aim of the present study was to compare the effects of 
HRT, DHEAS and T on endothelium-dependent flow mediated vasodilation (FMD), 
plasma nitrite, nitrate and endothelin-1 in 16 PMW with increased cardiovascular isk in a 
double-blinded double-crossover study. Women were randomized and treated for 4 
weeks with either HRT, T or DHEAS. Brachial artery diameter, FMD, endothelin-1 and 
plasma nitrite and nitrate levels were measured at baseline and after each treatment 
- phase.Brachial artery diameters remained unchanged after each treatment phase. HRT 
significantly improved FMD compared to both baseline and T and DHEAS while no effect 
of T or DHEAS on FMD was noted. 
In conclusion HRT but not either T or DHEAS improves endothelial function and reduces 
plasma levels of endothelin-t in PMW at risk of CAD. 
Effect of HRT, Tibolone or DHEAS on Endothelial Function 
Baseline HRT T DHEAS 
Brachial artery (mm) 4,06±0.3 4.0.7±0.3 4.07±0.2 4.06±0.3 
FMD (%) 7.3±0.8 11,94±0.8"* 6.9±0.5 6.4±0.9 
Nitrite+nitrate (Nox) 40 .6±11.7  48.4±7.8 39.9±8.2 34.7±11.8 
Endothelin-1 (pg/ml) 3.1±0,8 2.7±0.7* 3.1¢1.7 3.4±0.7 
*=p<0.05; **=p<0.01 
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1128-85 Effect of the Anglotenslnogen M235T Polymorphism on 
Human Coronary Vascular Endothelial FuncUon 
Julian Halcox. Suresh Narayanan, Abhiram Prasad, Colleen Satorius, William H. 
Schenke, Neal Epstein, Arshed A. Quyyumi, NHLB/, Bethesda, Maryland. 
Introduction: A missense substitution in exon 2 of the angiotensinogen gene (T704-C) 
encoding threonine instead of methionine at position 235 (M235T) may influence the risk of 
vascular disease. We hypothesized that this polymorphism is associated with coronary 
vascular endothelial dysfunction. 
Methods; Angiotensinogen M235T genotyping was performed in 118 Caucasian patients 
with mild coronary atherosclerosis (<50% stenosis) or angiographically smooth coronary 
artedes undergoing cardiac catheterization. Changes in coronary vascular resistance 
(~CVR) and epicardial artery diameter (aD) were measured as indices of microvascular 
and epicardial coronary vasodilator capacity during administration of intra-coronary acatyl- 
choline (ACH, 1511g/min), and sodium nitroprosside (SNP, 20pg/min), to test endothelium- 
dependent and -independent coronary vascular function, respectively. 
Results: 235T allele frequency was 0.40. Coronary microvascular dilation with ACH was 
reduced in TT compared to MT+'I-I" patients (SCVR: -36±9% vs -49±6%, p--O.04), whereas 
responses to SNP were similar in both groups (~CVR: .48±7% vs -54±2%, p=0.35]). In the 
epicardial coronary circulation, a net vasoconstrictor response with ACH was observed in 
l-r individuals, compared with a net vascdiletor esponse in MM+MT subjects (-5.2+~.3% 
vs +2.2±1.0%, p=0.003). Epicardial responses to SNP were similar in TT and MM+TT gen- 
otype groups (+23±5% vs +21±.2%, p=0.73). This impaired microvascular and epicardial 
coronary endothelial function observed in TT patients was independent of conventional dsk 
factors (age, gender, smoking, hyperlipidemia, diabetes, hypertension) for endothelial dys- 
function by multivariate analysis (~CVR: p=0.04 and 5D: p=O.03). 
Conclusions: individuals homozygous for the engiotensinogen 235T allele have impaired 
endothelium-dependent coronary artery vascdilation compared with MM+MT subjects. 
This finding provides mechanistic insight into the increased association between the 235T 
allele and hypertension, atherosclerosis, and myocardial infarction observed in several epi- 
demiologic studies. 
1128-86 Endothelial Dysfunction Following Radial Artery 
Cannulization 
Michael G. Del Core, Christopher Price, Lance LaMadrid, Kay Ryshon, Syed M. 
Mohiuddin, Creighton University, Omaha, Nebraska. 
Background: There is an increasing tendency to use arterial conduits, including the radial 
artery iRA), for coronary artery bypass surgery. At the same time, invasive cardiologists 
are increasingly using the RA as a conduit for cardiac catheterization. The purpose of 
this study was to assess endothelial function following RA cannulization. Methods: 20 
patients scheduled to undergo diagnostic catheterization via the radial approach under- 
went non-invasive evaluation of endothelial function. RA diameter was measured at 
baseline, then at 30 and 90 seconds following reactive hyperemia (endothelial depen- 
dent), and following administration of Nitroglycerin (endothelial independent). These 
measurements were obtained prior to catheterization, within 24 hours, at one week, and 
at one month following catheterization, Results: Reduced endothelial function in the RA 
was evident 24 hours after catheterization regardless of the dilation technique. Endothe- 
lial function measured at 1 week and 1 month in the radial artery was significantly 
improved over 24 hour values for nitro at 30 seconds (p=0.023 and p=0.016, respec- 
tively), and cuff at g0 seconds (p=0.045 and p=0.026, respectively). Nonsignificant 
improvements in endothelial function were evident at the remaining interventions 
between 1 week and 1 month. 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
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Conclusion: RA catheterization results in endothelial dysfunction following catheteriza- 
tion and may have implications for its use as an arterial conduit in coronary artery bypass 
surgery, 
1128-87 Effect of Xanthine Oxidase Inhibition on Endothelial 
Function in Smokers 
Sasidhar Guthikonda. Christine Sinkey, Theresa Barenz, William G. Haynes, Univeraity 
of Iowa, Iowa Ci~ Iowa. 
Background: Cigarette smoking causes endothelial dysfunction, possibly due to oxidant 
stress. One proposed mechanism has been generation of oxidant species by the enzyme 
xanthine oxidase (XO). We tested the hypothesis that XO impairs endothelial function in 
